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▪ The investment recommendation for Philip Morris International 
stock is a BUY, given the FY19 target price of $105,83 per 
share. Combined with an estimated cash dividend of $4,66, the 
implicit return on the investment, given the current share price 
of $66,76, is 65,5%. It is believed that the market is 
underestimating IQOS potential and consequent ability to 
capture market share. 
▪ In an environment characterized by stricter regulation, 
increasing taxes and declining volumes, PMI is channelling 
its resources to expand its reduced-risk segment, as a solution 
to overcome these challenges and strengthen its position in 
the tobacco industry, exploring its first-mover advantage in 
several markets. 
▪ The Asian region recorded a fivefold revenue growth in the 
reduced-risk products segment in 2017 and is expected to be 
the main growth driver with a forecasted revenue CAGR of 
3,2%. 
▪ Moderate organic growth is ensured for the following years, 
with a revenue CAGR of 2,8%, mainly supported by IQOS. 
▪ PMI stock has proved to be considerably volatile, shown by its 
wide 52-week range and annualized volatility of 33,9% in 2018. 
In the last two weeks, PMI’s share price decreased by 19,1%, 
resulting in a good opportunity to invest in the stock. 
Company description 
Philip Morris International is an international tobacco company 
engaged in the production and sale of cigarettes and other 
nicotine-containing products in 180 markets. 
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Cumulative return in % based on 100% 
Source: Bloomberg 
  
(Values in $ millions) 2017 2018 2019E 
Revenues (excluding excise 
taxes) 
28748 29535 30030 
EBITDA 12378 12552 12578 
EBITDA Margin 43,1% 42,5% 41,9% 
Net Profit 7365 9492 9477 
EPS ($) 4,74 6,11 6,10 
P/E ($) 21,53 10,93 17,36 
Source: Company Report; Analyst estimates 
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Company Overview 
Company Description 
Headquartered in New York, Philip Morris International Inc. (PMI) is an 
international tobacco company engaged in the production and sale of cigarettes 
and other nicotine-containing products in markets outside the United States. 
PMI’s vision is to build a future on smoke-free products which are assumed to 
be a better consumer choice than continuing to smoke conventional cigarettes 
and ultimately extinct regular cigarettes to the benefit of adult smokers, society 
and its shareholders. 1 
Until a spin-off in March 2008, Philip Morris International was operating under its 
parent company - Altria Group. As of today, PMI operates independently in more 
than 180 markets, under the support of around 81000 employees and reaching 
more than 150 million consumers worldwide. 2 
The company’s core business is segmented in two main categories of products: 
combustible products and reduced-risk products (RRPs). Combustible 
products are cigarettes and other tobacco products which include roll-your-own 
and make-your-own cigarettes, pipe tobacco, cigars and cigarillos. The company 
has a combustible portfolio of both international and local brands ranging from 
premium, mid-price and low-price categories. RRP is the term the company uses 
to refer to products that present or have the potential to present less risk of harm 
to smokers who switch to these products versus continued cigarette smoking.3 
The main feature of these products resides in the fact that they do not burn 
tobacco, heating it instead, and therefore considered potentially less harmful. The 
leading RRP brand, IQOS, was first introduced in Nagoya (Japan) in 2014 as a 
pilot project and consists of an electronic device into which a heated tobacco unit 
(HTU) is inserted and heated to generate an aerosol. 
 The company is operating within four geographic segments: European Union 
(EU); Eastern Europe, Middle East & Africa (EEMA); Asia; and Latin America 
& Canada. 
PMI uses the term net revenues to refer to its operating revenues from the sale of 
all their products, net of sales and promotion incentives. Furthermore, net 
revenues also include excise taxes billed to costumers, subsequently remitted to 
local governments. 
                                                 
1 Company Report 
2 Company data 
3 Company Report 
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Analysing the historical evolution of net revenues since 2015, when the sale of 
IQOS began, PMI was able to increase them from $73,9 to $80,1 billion in 2018, 
mainly driven by the increased sales of RRPs that accounted for around 77% of 
net revenues growth. Consequently, the share of RRP sales on net revenues 
reached 6,1% in 2018 (Exhibit 1), shifting from the 0,1% in 2015. 
Notwithstanding the remarkable RRP growth, between 2014 and 2016, the 
company’s net revenues excluding excise taxes (EET) decreased from $29,8 to 
$26,7 billion, mainly consequence of declining volumes within the industry. In 
2017, net revenues EET increased to $28,7 billion, despite a declining shipment 
volume, mainly due to price increases and favourable product mix. 4 Considering 
the four year period after IQOS launch, from 2015 to 2018, the company 
recorded a net revenues EET compounded annual growth rate (CAGR) of 2,46%. 
Regarding the historical evolution of RRP net revenues between 2015 and 2018, 
in the four geographic segments in which PMI operates, the main highlight   
consists in the substantial growth experienced by Asia. Accomplishing a RRP 
net revenue increase of around $4 billion, reaching a 17,5% share of Asia’s total 
net revenues and a 84,2% share of PMI’s RRP revenues in 2018 (Exhibit 2). 
Moreover, the outstanding performance of the Asian region is reflected in the net 
revenues EET share, when to comparing to the remaining geographic segments, 
resulting in an approximate 7 p.p. increase to 37,9%, in comparison to 2015. 
Consequently, the share of all remaining geographic segments on PMI’s total net 
revenues EET has been decreasing (Exhibit 3). As of 2018, Asia remains the 
major revenue contributor, followed by the European Union (Exhibit 4). 
                                                 
4 Company Report 
Exhibit 3: Net revenues distribution by region (2015 – 2018) 
Source: Company Report 
Exhibit 1: Net revenues by product 
category (2018) 
Source: Company Report 
Exhibit 4: RRP net revenue by region 
(2018) 
Source: Company Report 
Exhibit 2: RRP net revenue by region 
(2018) 
Source: Company Report 
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Share Performance 
 On March 19, 2008 Altria Group completed a spin-off of Philip Morris to its 
shareholders, resulting in the distribution all PMI shares in which each 
shareholder received one PMI share for every Altria common outstanding share. 
Since then, the stock began regular trading on the New York Stock Exchange 
(NYSE), as well as the NYSE Euronext Paris and SWX Swiss exchanges. 
Moreover, PMI has been a constituent of the S&P500 and the MSCI World 
indices. 5 
 Between 2014 and 2016, Philip Morris’ share price recorded a compounded 
annual growth of 6,9% mostly underperforming the market, partially due to its 
value nature being a high dividend stock, operating in a low growth mature 
industry. In the first two quarters of 2017, PMI’s share price recorded a CAGR of 
15%, outperforming the MSCI World and closing the gap to the S&P500, given 
the company’s overwhelming performance in the Asian market. Since then, PMI’s 
share price has been decreasing to past figures of 2016, due to the growth 
slowdown in the above-mentioned market6, however slightly reverting this trend 
in the last two quarters of 2018 (Exhibit 5). 
Comparing to its peers, Philip Morris recorded over the last five years a 
CAGR of 3,9%, slightly outperforming Imperial Brands, Japan Tobacco and 
British American Tobacco which recorded 0,2%, -1,8% and -4,7% respectively. 
Philip Morris mostly underperformed its peers until the end of 2016, however, its 
outstanding performance in the following two quarters allowed PMI to slightly 
reduce the impact of the generalized downwards trend felt across all industry 
since then, reflecting the struggle to globally shift from regular cigarettes to 
reduced-risk alternatives, while industry volumes keep decreasing (Exhibit 6). 7 
Management Team 
Philip Morris’ executive team is composed by 22 members led by its Chief 
Executive Officer André Calantzopoulos, who has been at the company for more 
than 30 years. He was named CEO and elected to the Board of Directors on May 
2013, after serving as Chief Operating Officer for more than 5 years. The Board 
is composed by 12 members, being Philip Morris’ CEO the only executive one, 
with Louis C. Camilleri as Chairman, a former CEO of the company.  
 
                                                 
5 Altria 2008 press release 
6 Company Report 
7 Fortune 
Exhibit 5: PMI stock performance 
against equity indices (2014 – 2018) 
Source: Bloomberg 
Exhibit 6: PMI stock performance 
against peers (2014 – 2018) 
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Shareholder Structure  
Philip Morris’ current shareholder structure is mainly composed by institutional 
investors, counting with more than 1700 and representing the largest investor 
group holding 74% of all shares, whereas individual investors account for less 
than 1%. The two above mentioned groups account for more than 57000 
shareholders. Philip Morris owns the remaining 25% through past repurchases as 
Treasury shares (Exhibit 7). 8 
At a geographical level, the US market accounts for 62% of all investors 
followed by the United Kingdom, Canada and Germany with 6%, 2% and 2% 
respectively (Exhibit 8). Within institutional investors, the asset manager 
Vanguard Group has the highest percentage of the outstanding shares at 7,65% 
followed by BlackRock at 4,18%, therefore not existing an investor holding the 
majority of voting rights. 9 
Dividend Policy 
Dividend policy has been a key factor in the past with PMI increasing annual 
cash dividend every year since becoming public in 2008, at a CAGR of 9,5%. 
Having one of the highest dividend yields among large-cap stocks, investors are 
often concerned about the sustainability of the company’s dividend payment as 
well as the high probability of a dividend cut.10 Therefore, PMI does not follow a 
target payout ratio has it aims at keeping a considerable dividend growth 
(Exhibit 9), not fully dependent of its performance. In the past, dividends have 
been higher than the company’s net income to meet investors’ expectations. 
                                                 
8 Company Report and Thomson Reuters 
9 Thomson Reuters 
10 Seeking Alpha 
Exhibit 9: Cash dividend historical evolution (2008 – 2018) 
Source: Company data 
2018 is the eleventh 
consecutive year in which PMI 
has increased its dividend 
Exhibit 7: Shareholder structure by 
investor type (2018) 
Source: Thomson Reuters 
Exhibit 8: Shareholder structure by 
geography (2018) 
Source: Thomson Reuters 
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Industry Overview 
Sector Analysis 
The most recent estimates for the global tobacco market indicate it is worth 
approximately $760 billion (excluding Chinese market that consists of a 
monopoly controlled by a state-owned company), where more than $680 billion 
come from the sale of conventional cigarettes11. 
It is estimated that more than 1,1 billion people smoke tobacco products, of which 
840 million smoke cigarettes12. Moreover, Euromonitor International estimates 
that international industry volumes, including cigarettes and heated tobacco units, 
were approximately 5,4 trillion units in 2017, a 1,3% decrease comparing to 
2016. This downwards trend has been driven by the increase of society’s health 
concern, illicit cigarettes sales, stricter regulation and higher taxation on tobacco 
products.  
One of the industry’s biggest concerns is related to the declining retail volumes 
that have intensified since 2012. According to a market research conducted by 
Euromonitor International, retail volume decreased around 530 billion units, 
resulting in approximately a 9% reduction from 2012 until 2017 (Exhibit 10). 
PMI’s shipment volume has also been decreasing since 2014, contributing to the 
industry’s declining volumes (Exhibit 11). 
Currently, the industry remits to governments over $401 billion in taxes, of 
which $331 billion and $70 billion are due to excise taxes and Value Added Tax 
(VAT), respectively. Furthermore, it is acknowledged considerable asymmetries 
in tax structures amongst countries, ranging from a 89,1% (Chile) to 2,3% 
(Afghanistan) tax per cigarette13. It is generally accepted that there is a positive 
correlation between taxes and illicit sales. The current high tax environment of 
the industry promotes the intensification of counterfeit cigarettes, which is 
estimated to already amount to 484 billion illicit cigarettes sold per year.14 
Regarding geographical distribution, industry sales are heavily concentrated in 
Asia, totalling a 64% market share of the global cigarette market in 2017 (Exhibit 
12). 
The tobacco industry is mainly controlled by 5 companies, jointly detaining 
81% of the global cigarette retail volume. China National Tobacco Corporation 
(CNTC), the state-owned company benefiting from a monopoly of the tobacco 
                                                 
11 British American Tobacco estimates 
12 Company data 
13 Company data 
14 Company data 
Exhibit 11: PMI shipment volume 
(Billion units) and annual % change 
Source: Company Report 
Exhibit 12: Global cigarette market by 
region (2017) 
Source: Euromonitor International 
Exhibit 10: Global cigarette retail 
volume (2011 – 2017) 
Source: Euromonitor International 
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market in China detains 43%, followed by PMI controlling the second largest 
retail volume share of 14% (Exhibit 13). Since CNTC operates in different 
business environment, the analysis mentioned before was replicated excluding 
the referred company (Exhibit 14). The concentration of the market is a 
consequence of the industry’s consolidation over the last decade, through a total 
of 261 mergers and acquisitions, amounting $127 billion15. Thus allowing the 
main players to improve its market position and creating a form of market that 
resembles to an oligopoly.  
The tobacco industry presents high entry barriers since newcomers would have 
to compete against very large conglomerates, benefiting from well-established 
economies of scale in manufacturing, branding, packaging and distribution 
network.16 Furthermore, the ban of tobacco advertisements could make it more 
cumbersome for smaller companies to widen their customer base. 
Peer companies 
PMI’s peer group was established based on a review of key characteristics that 
were considered fundamental for a company to be recognized as a comparable 
company of PMI. First, it was considered essential that companies’ core activity 
was the manufacture and sale of cigarettes and other nicotine-containing 
products. Secondly, selected companies should operate at a similar global 
scale. Ideally, peer companies should have a market capitalization and 
revenues similar to PMI’s, however, given the considerable dimension of PMI, 
these two factors were not considered as determinant as the ones mentioned 
above. Also considered relevant metrics are the Gross margin, as well as the 
EBITDA margin. When these margins are similar, companies exhibit comparable 
production and operational cost structures, enabling a more accurate 
comparison. 
It should be noted that CNTC was excluded from this analysis since it operates in 
a completely different business environment that makes the comparison 
unfeasible. Furthermore, Altria Group was also excluded from the peer group 
since it is a holding company that includes a significant number of subsidiary 
companies which its core activity is non-tobacco related and focuses its 
operations mainly in the U.S. 
The firms that fulfilled the above-mentioned requirements regarding similar core 
activity, global scale and revenues were therefore considered PMI’s comparables 
and are the following: British American Tobacco PLC (BAT), Japan Tobacco 
Inc. (JT) and Imperial Brands PLC (IMB). In terms of market size, BAT is the 
                                                 
15 Bloomberg 
16 Forbes 
Exhibit 13: Retail volume shares of 
global cigarette market (2017) 
Source: Euromonitor International 
Exhibit 14: Retail volume shares of 
global cigarette market excluding 
CNTC (2017) 
Source: Euromonitor International 
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closest to PMI, while the remaining two still have less than half their size. 
Regarding margins, BAT and JT present comparable figures whereas IMB still 
lacks improvements in its cost structure (Exhibit 15). 
 
British American Tobacco PLC is a publicly traded company based in London. 
BAT operates in over 200 markets and is market leader in more than 55 
countries. The company strengthened its global presence even further in 2017 
when acquired Reynolds American Inc., becoming one of the main players in the 
U.S. market and the third largest company in the global tobacco market, 
controlling an 11,8% market share. BAT has recently developed and incorporated 
heating tobacco products in their portfolio after launching a new device, Glo in 
December 2016. Moreover, the company expanded Glo to Canada and South 
Korea in 2017. 
Japan Tobacco Inc. is a publicly traded company headquartered in Tokyo with 
presence in more than 130 countries. The company became the fourth largest in 
the industry, controlling 8,4% of the global cigarette market and doubled its size 
after acquiring UK based Gallaher in 2007. JT continues to follow its strategy to 
expand the presence in emerging markets through organic growth and 
acquisitions. In 2016, the company launched the first heated tobacco product, 
Ploom Tech, in Japan and expanded production capacity in 2018 to market the 
product nationwide. 
Imperial Brands PLC is a publicly traded company headquartered in Bristol. It is 
present in 160 markets through its acquisition-driven strategy. IMB is the fifth 
largest company operating in the global tobacco market, controlling a 3,7% 
market share. The company’s key growth markets are mainly developed 
Exhibit 15: Financial metrics (USD billion) and % Revenues (2017) 
Source: Bloomberg 
  
 
PHILIP MORRIS INTERNATIONAL INC. COMPANY REPORT 
 
 
 
  PAGE 10/42 
 
 
 
countries such as Italy, Russia, Japan and Saudi Arabia. At the moment, IMB 
does not have a heated tobacco portfolio. 17 
Key Drivers 
Smoke-free Future 
Philip Morris is aiming to achieve a smoke-free future, supported by its 
smokeless reduced risk products and ultimately eradicate conventional 
cigarettes. PMI is channelling resources for the development of these 
products (Exhibit 16), in order to revert declining smoking rates as consumers 
become more aware of smoking related health issues. 
Launched in Japan in 2014, IQOS is now available in 43 markets around the 
globe (Exhibit 17) with around 6 million users switching from conventional 
cigarettes. Although only operating in less than a fourth of PMI’s overall market, 
RRPs already represent around 40% of marketing spending and are driving high 
capex (further discussed in the Capital Expenditures section) through the 
opening of new stores and increasing production capacity, emphasising the 
company’s commitment to this solution.18 
Besides the above-mentioned approach, Philip Morris is also currently taking 
several steps towards improving reduced risk products’ performance, in the face 
of a weaker growth in some regions and increased competitive pressure: 
- Introduction of the next generation IQOS devices by the end of 2018, with 
enhanced features, such as consecutive use, since current generation devices 
need to be charged for 6 minutes between uses; 
- Launch of a new tasting RRPs’ variant, closer to conventional cigarettes, to 
capture a greater share of the market; 
 - Launch of a lower price variant to attract price-sensitive consumers; 
- Simplification of the registration process for new consumers, eliminating entry 
barriers for older smokers less used to digital; 
- Marketing focused on more targeted and relevant communication content.19 
Consequently, PMI’s current strategy is expected to contribute with 
approximately $2,45 billion in net revenues from 2019 to 2021, driven by an 
improved market positioning in several key markets. 
                                                 
17 “The Global Cigarette Industry”, Tobacco-Free Kids Campaign (2018), peer companies’ websites and annual reports 
18 Company data 
19 Forbes 
Exhibit 16: R&D expense distribution 
by product type (2015 – 2018) 
Source: Company Report 
“Tobacco kills more than 7 
million people each year” – 
World Health Organization 
Exhibit 17: IQOS market presence 
evolution (number of countries) 
Source: Company Report 
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The momentum of IQOS in several European key cities (main launch markets 
apart from Japan and Korea) remains favourable, result of Philip Morris’ 
successful marketing and digital initiatives. As the marketing is limited to selected 
areas in the EU launch markets, the regional market share of around 1% is not 
really reflective of IQOS’ performance in the region. Instead, analysing the 
numbers of IQOS users in this region, which has increased by more than 
fourfold over the past year, to approximately 1.2 million, it can better indicate 
the product’s success.20 
As a crucial step in achieving a smoke-free future, PMI is awaiting approval from 
several regulatory authorities, particularly the US Food and Drug Administration 
to commercialize its reduced products under a differentiated regulatory regime 
and expects to enter the U.S. market in 2020. This important short-term goal 
represents a new considerable sized market to explore, as well as a crucial step 
in achieving its vision, assuming this entry could be seen as a sign of trust and 
accelerate similar processes with other regulatory agencies.21 
Regulation 
The health risks of smoking are well known by regulators whom have imposed 
year after year higher excise taxes on cigarettes (Exhibit 18). Moreover, costly 
regulation is applied in terms of packaging specifications, advertisement 
restrictions and smoking bans in enclosed public places. 
With over 1,1 billion smokers worldwide, a considerable proportion of the world 
population (Exhibit 19), a ban on cigarettes would be hard to impose. 
Furthermore, it would not be probable as taxes on cigarettes are a 
considerable revenue stream for governments, therefore the prospect for this 
industry is one of higher excise taxes following the historical trend. 
With the regulatory regimes applied to combustible products becoming 
significantly more demanding and representing a higher percentage of cigarette 
revenues every year, PMI believes that will be able to seek more favourable 
regulatory regimes through reduced risk products (lower overall excise tax 
rate observed in Exhibit 18 since 2017, driven by higher RRP volumes). As PMI 
CEO argues, tobacco products are not all the same and there is a need to 
educate consumers, reducing confusion about what these products are and what 
they stand for in terms of the potential benefits for their health (when compared to 
regular cigarettes).  
                                                 
20Company data 
21 Bloomberg Markets: Balance of Power 
“Approximately 10.000 people 
now switching from cigarettes 
every day” - PMI 
Exhibit 19: Smokers as percentage of 
world population (2018)  
Sources: World Health Organization, United 
Nations 
Exhibit 18: PMI’s total excise tax on 
products as % of net revenues       
(2011 – 2018)  
Source: Company Report 
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Regarding the pre-market regulatory assessments on tobacco products, these 
usually evaluate two major issues. Firstly, the potential of the product to reduce 
the individual risk for the consumer who permanently switched to it. Secondly, the 
impact on the population is evaluated regarding unintended uses or 
consequences of the product, for example, easier accessibility for underage or 
higher relapsing rates from people who already have quit. 22 
With over 400 researchers dedicated to developing and improving these 
products, and more than $4,5 billion spent since 2008 in R&D23, PMI believes 
that regulatory agencies throughout the world will accept and understand the 
benefits of these products, when assessing the previous maters. With more 
favourable regulatory regimes, IQOS could potentially be taxed at lower rates 
and its advertising be less restricted in terms of content and channels, improving 
contribution to earnings and stock performance. 
Economic Drivers 
There is empirical evidence that economic cycle has an impact in the 
performance of the tobacco industry, as during recessions, cigarette 
consumption decreases.24 In the context of an economic slowdown, 
unemployment rates increase and consequently lead to a reduction of disposable 
income, followed by a drop in consumption and therefore increase the relative 
price of tobacco products. Since cigarettes are not a primary good, it is expected 
that consumers trade down to cheaper alternatives and eventually quit 
smoking.25 Economic conditions, through nominal GDP growth, are therefore 
considered a significant driver of the tobacco market. 
Industry cyclicality combined with low bargaining power of consumers (due to 
its addictive nature, making cigarette demand generally more price inelastic) 
promotes the development of a strong pricing power that helps offsetting 
declining volumes (Exhibit 20), although partially during recessions.26 Moreover, 
according to PMI, HTUs are sold at a price similar to premium combustible 
products, generally across all markets, and also maintaining a price inelastic 
behaviour. Therefore, as this type of product is becoming a representative 
segment in the tobacco market, despite declining volumes within the industry, the 
market size in USD is expected to steadily increase (Exhibit 21). 
The development level of each country directly influences technological diffusion. 
In line with current PMI strategy, IQOS’ launches have been targeting 
                                                 
22 CNN Money Switzerland: Executive Talk 
23 Company Report 
24 Kaiser, M. et al. (2017) Smoking and the Business Cycle: Evidence from Germany. IZA Institute of Labor Economics 
25 Company Report 
26 Value Line 
Exhibit 20: Global cigarette market: 
Historical retail volume and current 
retail value (2011 – 2017) 
Source: Euromonitor (2018) 
Exhibit 21: Global tobacco market size 
(PMI operating markets, 2018 - 2025) 
Source: Analyst estimates 
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developed countries and therefore, subsequent releases are expected to be 
prioritized to these types of geographies, with higher technology adoption 
propensity. Thus, after-launch market conditions for developing countries are 
also expected to be less favourable, resulting in slower IQOS growth when 
compared to developed ones. 
Forecasting Assumptions 
Revenues 
PMI total revenues are segmented by four main regions, as reported by the 
company. Within each region, the segmentation is done at more precise level in 
which the most relevant reported countries are considered. The residual revenue 
from all remaining countries is analysed separately, maintaining a constant 
proportion relative to the reported countries, including the expansion component 
of RRPs in each region. Moreover, forecasts are driven by three main variables: 
market size, market share and reduced-risk ratio. 
As mentioned before, GDP growth is considered a main driver to forecast 
each country’s tobacco market size, being the latter the value of all tobacco 
products sold in USD. The relationship between GDP growth and market growth 
was regressed and proven to be statistically significant at a 10% significance 
level for homogeneous regions. Therefore, this driver forecasted until 2022, by 
the International Monetary Fund, is able to explain market behaviour and 
considered a relevant proxy (Exhibit 22).  
PMI’s market share in each country is forecasted based on recent historical 
performance, country specific risks and competitors’ performance resulting 
in a short-term analysis going forward. For all major countries, except for 
Canada, Japan and Korea, PMI is dominating the heated tobacco segment facing 
no competition up to this date. Although competitors have entered the heated 
tobacco market in the three above mentioned countries, other market launches to 
occur within the short-term frame may not necessarily be successful in 
supplanting PMI’s first-mover advantage, only ending the initial period of 
unchallenged dominance for IQOS. Therefore, market shares are estimated 
from 2 to 3 years forward, with changes resulting from PMI’s first-mover 
advantage and strategy for its reduced-risk segment (referred in the Smoke-Free 
Future section). Thereafter, market shares are considered to stabilize, as a result 
of its peers’ reaction. 
Although only marketing IQOS in 43 markets worldwide, PMI’s goal of achieving 
a smoke-free future implies increasing the reach of its heated tobacco products 
Exhibit 22: Relationship between GDP 
and tobacco market growths in the 16 
forecasted countries (2015 – 2017)  
Sources: Company Report, International 
Monetary Fund 
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at a global scope. According to the company’s estimates, PMI expects its 
revenue from reduce-risk products (excluding excise taxes) to be around $17-$19 
billion in 2025, approximately 38%-42% of PMI total net revenues (at today’s 
pricing and excise taxes assumptions). Given this assumption, the reduce-risk 
ratio (RRP’s revenue as a percentage of total revenue) is forecasted based on 
RRP’s ability to penetrate within each market, keeping in mind an average 
target of 40% for 2025, reached at a compounded annual growth rate. Evidently, 
RRP’s performance and ability to convert regular cigarette consumers will vary 
between countries given their intrinsic nature, values and openness to 
technological developments. Consequently, less developed countries are not 
as likely to reach the set target whereas developed ones may surpass it. In 2025, 
the reduced-risk ratio estimate fell below PMI’s above-mentioned target reaching 
only 29,4% (Exhibit 23), driven by its expected inability to introduce IQOS in 
some of its key markets, mostly due to government bans. 
 
The combustible and reduced-risk products’ revenues for each country are 
computed through the combination of these aforementioned drivers. 
▪ European Union 
Within the European Union, heated tobacco products are expected to penetrate 
the market, mainly due to a substitution effect and, consequently, the reduced-
risk ratio is estimated between 40% and 45% for 2025, based on IQOS historical 
performance and given the developed and homogeneous nature of these 
countries. Revenues are forecasted at a 10y CAGR of 2,4% (Exhibit 24), mostly 
Exhibit 23: Reduced-risk ratio segmented by region (2014 – 2025) 
Source: Analyst estimates, Company Report 
Exhibit 24: EU net revenue by product 
type (2015 – 2022) 
Source: Analyst estimates, Company Report 
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driven by a stronger market positioning and steady economic growth within the 
region. 
Market share in France has grown 3,0 p.p. from 2014 to 2018, mostly driven by 
combustible products’ strong performance in premium brands.27 Furthermore, 
IQOS was launched in 2017, reaching sales of 32,5 million, enhancing the growth 
of the market share, even though up to this date, the distribution of IQOS is done 
only in 3% of tobacco shops in the country. 28 In this context, the market share is 
forecasted to grow from 44% in 2018 to 46,5% in 2021. In Poland, the market 
share is also expected to increase in the short-term, in line with the positive 
historical performance observed. In 2021, the market share is forecasted at 
46,5% compared to the 44%, four years before. Regarding Germany, Italy and 
Spain, market shares have shown stagnation in the past and, given the inability 
of PMI to gain market share from its peers in an environment without HTU 
competition, they are expected to remain constant going forward. 
▪ Eastern Europe, Middle East & Africa 
EMEA forecasts for IQOS penetration and market presence are more 
conservative with reduced-risk ratio varying between 35% and 40%, mostly due 
to political instability, strong illicit trading presence within the region and the 
developing nature of some of its countries. Therefore, revenues are forecasted at 
a 10y CAGR of 2,2% (Exhibit 27) in line with tobacco market growth. 
Philip Morris shows no plans of expanding its heated tobacco operations into the 
North African region in the short/medium term, relying on its combustible 
products. Market shares have been fluctuating around an average 25,3% in 
previous periods and therefore, expected to go forward in line with this figure.  
Concerning the Russian tobacco market, PMI stands behind JT which is 
currently market leader.29 However, JT and all other peers are not marketing 
heated tobacco products such as IQOS, enhancing the first-mover advantage of 
PMI. In this context, IQOS has shown a positive performance and expected to be  
pivotal in strengthening market positioning in this region with market share 
forecasted to increase by 1,0 p.p. until 2020.  
Regarding Turkey, market share has shown stagnation, however, based on 
PMI’s solo player competitive advantage in the HTU segment, coupled with a 
strong distribution network serving around 143.000 sales outlets in 81 cities 
throughout the country30, market share is expected to grow 1,5 p.p. until 2021. 
                                                 
27 Company Report 
28 ECigIntelligence - Market Report 
29 Bloomberg 
30 Source: Philip Morris International 
Exhibit 27: EEMA net revenue by 
product type (2015 – 2022) 
Source: Analyst estimates, Company Report 
Exhibit 25: EU market share by 
country (2015 – 2022) 
Source: Analyst estimates, Company Report 
Source: Analyst estimates, Company Report 
Exhibit 26: EU market size in $ billion 
by country (2015 – 2022) 
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 In Ukraine, both Philip Morris and its peers have been losing market to illicit  
traders as a result of a repeated unpredicted increase in excise duty rates for 
cigarettes.31 Although showing a positive IQOS performance coupled with 
Ukrainian approved legislation in 2017 to fight illicit trade, given the country’s 
political instability, market share is forecasted to remain stable into the future. 
▪ Asia 
Due to asymmetries in the countries belonging to Asia, this region shows no 
statistical evidence of a strong relationship between GDP growth and tobacco 
market growth, in contrast with all other regions. To overcome this issue, the 
relationship in this region was assumed to be similar to the one observed 
worldwide. Regarding IQOS penetration, it is highly significant for both Japan and 
Korea whereas for most countries, due to their cultural nature and legal    
constraints, reduced and/or non-existent. Driven by fundamentally strong 
combustible portfolio and strong IQOS performance in the above-mentioned 
countries, revenues are forecasted at a 10y CAGR of 3,2% (Exhibit 30). 
Launched in 2014, IQOS was firstly introduced in Japan, where it faced no 
competition in the heated tobacco segment until 2016, when BAT and JT 
launched similar products, Glo and Ploom Tech, respectively. This strong market 
positioning coupled with the ban on e-cigarettes (allowing IQOS to compete 
directly with regular cigarettes) and consumers preference for less harmful and 
more technologically advanced products, allowed PMI to experience an abnormal 
growth of 6,2 p.p. in the last four years. PMI’s market share is forecasted to 
stabilize in the short-term due to the lower price at which these competitive 
products are marketed. According to its CEO, PMI is already implementing the 
right marketing and product measures, through a new line of cheaper devices, to 
reinvigorate growth in Japan, although not expected to pay-off until 2019.32 
Furthermore, the reduced-risk ratio is expected to reach 70% by 2025, a 15,7 
p.p. increase from 2018. 
 In June 2017, IQOS was launched in South Korea with an overwhelming 
performance, achieving in the same year $145 million of RRP revenue, although 
competing with BAT’s heated tobacco product - Glo. South Korean government 
claims to have found, in recent test results, harmful substances in heated 
tobacco products such as IQOS. Despite Philip Morris already filling a lawsuit 
opposing such claim33, consumers became confused about using alternative 
tobacco products over conventional ones. Consequently, market share growth is 
                                                 
31 Source: Imperial Tobacco 
32 Financial Times 
33 Financial Times 
Exhibit 28: EEMA market share by 
country (2015 – 2022) 
Source: Analyst estimates, Company Report 
Exhibit 29: EEMA market size in         
$ billion by country (2015 – 2022) 
Source: Analyst estimates, Company Report 
Exhibit 30: Asia net revenue by 
product type (2015 – 2022) 
Source: Analyst estimates, Company Report 
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expected to slow down in the following years. Moreover, the reduced-risk ratio is 
expected to reach 40% by 2025, a 26,5 p.p. increase from 2018. 
PMI’s market share in Philippines has been decreasing in the past few years 
and lately, particularly in low price brands, due to the timing of competitor’s price 
increases. In the third quarter of 2018, market share has already climbed to 
69,5% and expected to increase by 4,1 p.p. until 2021, reaching recent historical 
figures. 34 PMI has been losing market share in Indonesia mainly due to the soft 
performance of some brand portfolios, higher levels of illicit trading and 
competitors’ discounted product offerings, therefore, the market share is 
expected to follow this historical trend. For these last two mentioned countries, 
Philip Morris does not expect to launch IQOS, at least for the time being. In 
Philippines, PMI is focused on growing its combustible products portfolio, 
whereas in Indonesia, electronic smoking devices such as IQOS are 
government banned.35 
▪ Latin America & Canada 
 The low presence of reduced-risk products in this region comes as a 
consequence of legal constraints and economic instability. Canada remains 
pivotal as the main IQOS driver, currently deploying a countrywide expansion 
strategy. Revenues are therefore mainly driven by PMI’s combustibles’ portfolio 
with a 10y CAGR of 2,37% (Exhibit 33). 
IQOS was launched in Canada in 2016 followed by BAT’s launch of Glo in 2017. 
Despite PMI’s market share been fluctuation around 37,7% and with 
strengthened competition, the company is deploying an expansion strategy.36 
Based on a series of touchpoints that together create a unique ecosystem, PMI is 
opening owned retail stores, betting on online commerce, and working on  
partnerships in existing retail networks, resulting in an expected market share 
increase from 38,4% in 2018 to 41,8% in 2021. Additionally, the reduced-risk 
ratio is expected to reach 45% by 2025, a 44,2 p.p. increase from 2018. 
In Mexico, market share has been slightly decreasing due to competitive 
pressure in the low-price segment Delicados,37 however, this effect is not 
expected to be significant going forward, with the forecasted share remaining 
stable. IQOS is not expected to be launch in the above market as Mexican law 
forbids the use of electronic smoking devices.38 
                                                 
34 Company Report 
35 Nikkei Asian Review, Tobacco Reporter 
36 Retail Insider 
37 Company Report 
38 Press Reader 
Exhibit 31: Asia market share by 
country (2015 – 2022) 
Source: Analyst estimates, Company Report 
Exhibit 32: Asia market size in $ billion 
by country (2015 – 2022) 
Source: Analyst estimates, Company Report 
Exhibit 33: Latin America & Canada 
net revenue by product type (2015 – 
2022) 
Source: Analyst estimates, Company Report 
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Regarding Argentina, revenues are expected to decrease as the economy faces 
a currency crisis resulting in high inflation.39 Not only the tobacco market is 
expected to shrink during the next two years, but also PMI’s market share is 
forecasted to decrease as consumers seek cheaper alternatives to premium 
brands, coupled with local manufactures’ exemption from paying minimum excise 
tax in the low-price segment.40 Similar to Mexico, Argentina also forbids the use 
of electronic smoking devices41, therefore IQOS is not expected to be released in 
this market in the foreseeable future. 
Excise Taxes 
PMI argues that excise taxes on reduced-risk products are generally lower 
than conventional combustible products’ taxes.42 In fact, countries have 
different attitudes and views towards reduced-risk products which results in 
asymmetric governmental actions when regulating and taxing these products. As 
mentioned before, several countries, particularly in Asia and Latin America 
demonstrate a conservative view towards RRPs, implementing bans on their 
commercialization or taxes in line with cigarettes. On the other hand, countries 
within the European Union, must comply with a regulatory framework that 
enables them to tax RRPs as they perceive to be fit, although above the 
harmonised minimum set by the European Commission Directive of 20% of the 
retail selling price. In contrast, cigarettes’ minimum excise tax is set to be 60%. 
Currently, Japan, South Korea and three countries in the EU - Portugal, Italy and 
Hungary43 - are among the ones that apply an excise tax rate for RRPs lower 
than those applied for cigarettes. 
PMI sets its expectations in a worldwide acceptance of lower taxes for reduced-
risk products, on the basis that by reducing tobacco related externalities, these 
less harmful products should be taxed at lower rates. However, 
intergovernmental institutions and sovereign authorities still need to assess and 
ensure that RRPs are significantly less harmful for consumers’ health than 
combustible products, in order to materialize those expectations. Furthermore, 
tobacco excise taxes are a significant source of funds for many countries which 
leads to a lobbying movement of governments against lower taxes on 
tobacco products.  
                                                 
39 Bloomberg 
40 Company Report 
41 Fortune 
42 Company data 
43 European Commission 
Source: Analyst estimates, Company Report 
Exhibit 34: Latin America & Canada 
market share by country (2015 – 2022) 
Exhibit 35: Latin America & Canada 
market size in $ billion by country (2015 
– 2022) 
Source: Analyst estimates, Company Report 
Exhibit 36: Excise tax on products by 
region as % of net revenues (2018 – 
2028)  
Source: Analyst estimates 
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In this context, excise taxes in percentage of revenues are forecasted to 
remain constant going forward (Exhibit 36) as these diverging forces are 
expected to offset each other, neutralizing the past upward trend (Exhibit 18). 
Operating Costs 
The company segregates its operating costs in 5 major captions: cost of sales 
(COGS), marketing and administration costs, advertising expenses, rent 
expenses and R&D (Exhibit 37). 
Cost of sales are expected to slightly increase as percentage of revenues in 
the short-term, result of the company’s increasing capacity, reverting its 
economies of scale achieved in the combustible segment by switching a 
considerable part of production to RRPs. Moreover, this caption includes costs 
related to IQOS devices, produced by third-party manufacturers. These are 
marketed at lower margins given the competitors’ pressure through lower priced 
similar products. Notwithstanding, IQOS’ unit costs have already decreased by 
15% in 2017, offset by introductory discounts of approximately 25%.44 
Further in the future, gross margin is expected to improve and revert to 
63,7% by 2028, slightly below the industry median of 64,3%, as economies of 
scale in reduced-risk products are developed. This assumption is corroborated by 
Philip Morris, assuming that their RRPs segment has the potential to reach 
margins in line with premium cigarette brands.45 
Marketing and administration costs are mostly related to operations and 
management and have been following a downwards trend in the past few years, 
suggesting efficiency improvements within the business model. This caption as 
percentage of revenues remained stable from 2016 to 2018, and consequently 
expected to remain constant at 15% of revenues going forward, slightly 
below the industry median of 15,5%.46 
Advertising expenses are expected to increase in the short-term as the 
company is currently supporting heavily the marketing of reduced-risk products. 
In 2017, PMI spent an additional $325 million in advertising, reflecting increased 
investment behind reduced-risk products. From 2021 onwards, advertising costs 
are forecasted to remain constant at 4,2% of revenues, as the company’s 
market positioning in the RRPs segment becomes strong and the product well 
established. Rent expenses are forecasted to follow a slight increasing trend 
in line with PMI’s expansion plans as the retail stores network grows, 
supporting the diffusion of its reduced-risk segment. 
                                                 
44 Company data 
45 Company data 
46 Thomson Reuters 
Exhibit 39: Marketing and 
administration costs in $ billion (2015 – 
2023) 
Source: Analyst estimates, Company Report 
Exhibit 37: Distribution of operating 
costs (2018) 
Source: Company Report 
Exhibit 38: Cost of sales in $ billion 
(2015 – 2023) 
Source: Analyst estimates, Company Report 
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Since 2008, Philip Morris has been developing RRPs spending over $4,5 billion 
in R&D. Being this product’s success fundamental in achieving PMI’s vision, the 
company expects to maintain investment levels on R&D at 1,5%, in line with 
the industry median of 1,6%, as new iterations of its products are already being 
marketed and developed. To prove consumers and authorities that these 
products are indeed less harmful than regular cigarettes, the company is 
committed to spending a considerable amount of its R&D budget on testing, a 
crucial step in achieving differentiated regulatory regimes. 
 
 
 
 
 
 
 
Capital Expenditures 
Regarding Capital Expenditures, Philip Morris does not disclose forecasted 
figures other than the CAPEX for 2018 of approximately $1,5 billion, already 
down 12% from the previously disclosed $1,7 billion. This reduction reflects 
primarily lower spending on reduced-risk manufacturing equipment due to 
increased production efficiency, as well as lower spending on manufacturing 
plants due to dual-production flexibility at existing facilities. 
Being 29% lower when compared to 2017, the 2018 CAPEX figure reflects the 
company’s planned strategy for this year to consolidate its presence in the 43 
established markets for IQOS, and thereafter increase its global reach. In 
contrast, in 2017, PMI spent more than $2,0 billion on capital expenditures, result 
of the IQOS expansion to 18 new markets and a $300 million investment to 
convert the cigarette manufacturing plant of Papastratos, PMI’s affiliate in 
Greece, into a facility to produce the tobacco sticks to be used on IQOS. 
In 2018, reduced-risk related CAPEX already represents approximately 60% of 
total capital expenditures, despite reduced-risk revenues being only 6% of total 
PMI revenues. This allocation is expected to remain high and increase going 
forward as the company’s vision of a smoke-free future depends on increasing  
Exhibit 44: PP&E as % of revenues 
(2018 – 2026) 
Source: Analyst estimates, Company Report 
Exhibit 40: Advertising expenses in $ 
million (2015 – 2023) 
Source: Analyst estimates, Company Report 
Exhibit 42: R&D expenses in $ million 
(2015 – 2023) 
Source: Analyst estimates, Company Report 
Exhibit 41: Rent expenses in $ million 
(2015 – 2023) 
Source: Analyst estimates, Company Report 
Exhibit 43: Operating cost captions as % of revenues (2014 – 2028) 
Source: Analyst estimates, Company Report 
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production capacity to match reduced-risk products’ demand, as well as on a 
strong distribution network of owned physical retail stores. In the short-term, 
capital expenditures are expected to increase due to its strong expansion 
component (Exhibit 45), which is expected to decrease from the 2024 onwards, 
as PMI’s reduced-risk segment achieves a stronger global presence.47 
Net Working Capital 
As Philip Morris is under an expansion plan and changing the business model, its 
short-term capital needs are expected to increase. By only analysing the 
historical figures of the company’s Net Working Capital, as percentage of 
revenues and cost of sales, the forecasts would not be accurate due to the 
changing environment. All current assets and liabilities that derive from 
operational activities were included in the NWC and analysed against the 
median of its peers, considered as an industry proxy (Exhibit 46). 
Consequence of the bet on reduced-risk products, it is expected that the 
company’s cash conversion cycle increases in the following years. As the 
company relies on new IQOS suppliers, its average payable period is 
forecasted to decrease from the current value of 78 to 72 days in 2028, when 
comparing to the past business model in which conventional cigarettes were 
mostly self-produced. In contrast, as the turnover of IQOS devices is lower than 
cigarettes, retailer’s cash conversion is expected to amplify and consequently 
increase PMI’s average collection period from 45 days in 2018 to 62 in 2028. 
Furthermore, as the reduced-risk segment is expected to become more relevant, 
inventories are forecasted to increase to 35,2% of total revenues by 2023 (a 
2,5 p.p. increase from 2018), supporting future IQOS demand. 
Dividends 
As mentioned before, cash dividends play an important role in meeting investors’ 
expectations and consequently sustaining share performance. As announced by 
PMI in 2018, dividend growth will remain a key priority going forward.48 
Therefore, dividends are expected to increase, however, its growth is forecasted 
to slow down from 3,8% in 2019 to 2,8% in 2024, converging to a sustainable 
growth in line with the perpetual growth rate (Exhibit 48). 
 
 
                                                 
47 Company data 
48 Company data 
Exhibit 45: Capital expenditures in      
$ million (2018 – 2026) 
Source: Analyst estimates, Company Report 
Exhibit 46: PMI against industry peers 
acitivity’s efficiency ratios (2018) 
Source: Analyst estimates, Company Report 
Exhibit 47: Main NWC items in            
$ million (2018 – 2026) 
Source: Analyst estimates, Company Report 
Exhibit 48: Estimated cash dividend and % growth (2019 – 2028)  
Source: Analyst estimates 
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Valuation 
Relative Valuation 
The use of a relative valuation methodology with comparable companies can be 
useful to triangulate the DCF valuation outcome. However, one should bear in 
mind that valuation models not based on forecasted cash flows are limited in their 
applicability since they do not take into account the expected development of the 
company, a crucial factor to determine the company’s value, based on its future 
ability to generate cash. Moreover, there is a considerable margin of error due to 
implementation issues, rising from the selection of comparables that might not 
be pure players and consequently bias the valuation. In addition, the target 
company’s share price is determined from the market value of comparables’ 
multiples, which are not guaranteed to be efficiently priced by the market, 
translating into a circularity issue. 
The valuation was performed with 3 broadly used multiples in the investment 
community: EV/Revenues, Price-to-earnings ratio (P/E) and EV/EBITDA, with 
the latter being also used for a Precedent Transaction analysis. According to 
McKinsey’s valuation book, enterprise value to EBITDA is the best multiple for 
comparing valuations across companies, since P/E ratio is distorted by the 
company’s capital structure and non-operating gains and losses. On the other 
hand, EV/Revenues is distorted by the company’s cost structure that is not 
captured in this ratio. Despite these facts, all 3 multiples were considered in order 
to obtain a wider perspective. 
As recommended by McKinsey’s book, the valuation comprised forward-looking 
multiples computed with projected financial metrics in the denominator, estimated 
by Thomson Reuters. Rather than last year’s reported figures, forward-looking 
multiples provide a more future-centred estimate and theoretically more accurate. 
Furthermore, due to recent bearish market behaviour, strongly affecting share 
performance, it was also thought appropriate to use through the cycle 
multiples, which were computed using the figures from 2014 onwards. 
The results of the relative valuation are displayed in Exhibit 49 and, as mentioned 
above, the limitations of this methodology coupled with the significant impact of 
current market fluctuations in the forward-looking multiples, call for reservations 
regarding the conclusions that can be withdrawn from this analysis. 
Discounted Cash Flows Method 
Supported by the companies’ forecasted cash flows, the enterprise value of PMI 
was calculated through the most common and frequently used valuation 
Exhibit 49: Relative Valuation: Peers’ 
Multiples (2019 share price in $) 
Source: Bloomberg, Thomson Reuters 
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methodology - the Discounted Cash Flows Method (DCF). This methodology 
consists in discounting the future cash flows of the company at the appropriate 
cost of capital – the Weighted-Average Cost of Capital (WACC). 
PMI has a capital structure composed by both equity and financial debt that 
fluctuate each year along with the enterprise value, resulting in a changing 
WACC driven by a fluctuant debt to equity ratio as the company’s capital 
structure is adjusted (Appendix III). 
The DCF method splits the estimation of the future cash flows into two segments, 
the estimated cash flows for each forecasted year, in this case until 2028, and 
the terminal value, that together represent the value of the company’s core 
operations. The terminal value computation requires the company to have 
already achieved steady-state of its operations, given by a constant growth of the 
Net Operating Profit Less Adjusted Taxes (NOPLAT). 
▪ WACC Assumptions 
WACC’s computation requires the company’s debt to equity ratio, cost of 
equity, cost of debt and applicable marginal tax-rate. In this context, each of 
these inputs was estimated (Exhibit 50). 
Through the same WACC’s calculation methodology, the cost of equity was 
computed under the Capital Asset Pricing Model (CAPM) assumptions for each 
forecasted year, considering the three following inputs: risk-free rate, market 
risk premium and beta of equity. 
The risk-free rate was inferred from a 10-year US Government Bond, given the 
fact that Philip Morris, being based in New York, declares its financial statements 
in US dollars and the bond maturity matches the one of the forecasted cash 
flows. This debt instrument is considered to be a good proxy of risk-free debt, 
given its low risk nature, namely default and reinvestment risks, as well as its 
considerable liquidity. The risk-free rate was then considered to be the 3,19% 
yield to maturity of this bond. 
The market risk premium was set at 5,50%, which is a consensual figure 
among the investment community for the excess return investors expect when 
holding the market portfolio.49 
As for the final variable, the beta of equity (levered) was computed with the 
unlevered beta of the industry as input, assumed to be the median of the peer 
companies and PMI itself (Exhibit 51). Thus, enabling the calculation of PMI’s 
cost of equity for each forecasted year, adjusting for capital structure’s changes 
                                                 
49 Mckinsey Valuation “Measuring and Managing the Value of Companies” 
Exhibit 50: WACC components 
(calculation for perpetuity) 
Source: Bloomberg 
Exhibit 51: Peer companies’ equity 
beta and industry median 
Source: Bloomberg 
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(Appendix III). The calculation of the unlevered beta of the industry required the 
computation of the forward-looking betas of the companies, which was derived by 
regressing the 2-year weekly stock returns of each company on the MSCI 
World index returns. This equity index is considered to be a good market proxy 
serving as a broad representation of the overall stock market, given its diversified 
sectoral and geographical nature. Due to past fluctuations of the equity raw beta, 
observed in its current wide confidence interval (CI) of [0,28;1,01] (Exhibit 52), 
the assumptions for the beta will be later challenged through a sensitivity 
analysis. 
PMI’s cost of debt was computed with the following inputs: yield of a 10-year 
bond issued by PMI, the corresponding annualized probability of default and 
the loss given default for this type of security. Therefore, the cost of debt was 
derived from the 10-year bullet senior unsecured bond issued by PMI in 2014 
with an YTM of 3,78%, deducted by the product of the annualized probability of 
default and the loss given default ratio (LGD). The calculations of the last two 
inputs was based on a Moody’s study on default that directly links the annualized 
probability of default to PMI’s A2 credit rating. Consequently, the pre-tax cost of 
debt used to compute the WACC was 3,69% (Exhibit 53). 
▪ Perpetual Growth  
Through an explicit forecasted period of 10 years, the model arrived at a 
steady state with a NOPLAT’s growth rate of 2,8% (Appendix 3). Considered to 
compute the Terminal Value, the perpetual growth rate is slightly above the 
estimated long-term inflation rate of 2,2%, resulting in a positive expected real 
long-term growth. This assumption will be further challenged through a 
sensitivity analysis. 
Final Considerations 
PMI’s equity market value, as of December 2019, was estimated to be $164,51 
billion, given by the combination of the core operations’ enterprise value and the 
market value of non-core operations, deducted of the company’s market value of 
net financial debt and minority interests. With an approximate of 1,55 billion 
shares outstanding, PMI’s target share price is forecasted at $105,83. 
Considering a cash dividend to be paid in 2019 of $4,66, the 1-year shareholder 
return is estimated at 65,5% resulting in a BUY recommendation. 
To assess the reasonability of the assumptions behind the valuation, one must 
analyse the value creation metrics implicit in the projections and the respective 
cost of capital. Regarding the return on invested capital (ROIC), it has been 
decreasing throughout the forecasting period, driven by lower returns on new 
Exhibit 52: Rolling 2-year PMI’s equity 
beta and respective CI (2014 – 2018) 
Source: Bloomberg 
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Exhibit 53: PMI’s cost of debt 
calculation 
Source: Bloomberg 
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invested capital (RONIC) ranging from 9,7% to 13,1%. However, with RONICs 
higher than PMI’s maximum registered cost of capital of 6,90%, the company is 
able to generate value to its shareholders. In addition, the implicit RONIC 
observed before perpetuity is 12,7%, larger than the WACC of 6,90% but 
considered to be sustainable in the long-run, given the mature nature of the 
tobacco sector and its high entry barriers (Appendix 3). 
Sensitivity Analysis 
In order to determine the reliability of the Discounted Cash-Flows Model, one 
must challenge its assumptions through a sensitivity analysis of the inputs 
considered most relevant: perpetual growth rate and unlevered beta.  
Given the considerable proportion of the Terminal Value on the Enterprise Value 
(Exhibit 54), the impact of the perpetual growth rate on the estimated target 
share price was assessed. Moreover, due to the disruptive environment in this 
industry, departing from traditional tobacco products, the unlevered beta was also 
included in the above-mentioned analysis to evaluate the impact of changes in 
systematic risk of the core business.  
The target price was forecasted under variations of the unlevered beta within the 
interval of [0,55;0,85], with the lowest corresponding to PMI’s unlevered beta 
resulting from a 2-year historical analysis of its weekly returns against the market. 
This is one of the most impacting WACC components, which directly affects the 
present value of all forecasted cash-flows, thus the target share price. The cost of 
debt was not included in this analysis since there are no planned debt issues nor 
PMI’s credit rating expected to suffer changes. 
Through this analysis (Exhibit 55), the target share price is estimated to be in a 
range, so that the current investment recommendation is maintained. 
 
 
 
 
 
Exhibit 54: Enterprise value 
distribution  
Sources: Analyst estimates 
Exhibit 55: Target share price sensitivity analysis 
Source: Analyst estimates 
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Scenario Analysis 
The analysis was structured to assess the impact of the following business risks 
to the company: excise tax variations and gross margin deterioration. Excise 
taxes have been increasing in the past, as percentage of revenues. Regarding 
the gross margin, it has been decreasing as PMI departs from its well-established 
economies of scale, due to changes in its business model. 
To analyse the above-mention business risks, three hypothetical cases were 
considered: the base-case – reflected in the DCF valuation, which includes the 
scenario believed to be the most likely to occur -, the optimistic and the 
pessimistic cases.  
For the development of the optimistic scenario, it was considered that within 
the EU region, excise taxes for RRPs going forward are lower than the ones for 
regular cigarettes, result of more favourable regulatory regimes. This effect can 
be broadly applied to the entire region due to the organisational structure of the 
European Union, which mandates directives applicable to all countries within its 
jurisdiction. Therefore, excise taxes as percentage of revenues are expected to 
decrease going forward as the reduced-risk ratio increases, on the basis that 
excise taxes for RRPs are set at 30% in 2019, above the current minimum 
guidance of 20%. Thereafter, taxes for both RRPs and regular cigarettes are 
expected to increase at 0,41% a year, reflecting past growth trends. Additionally, 
in 2023, gross margin is expected to improve to 63,7% after the initial 
deterioration stemming from the upward scale of RRPs.  
This scenario results in an expected target share price of $135,89, reflecting no 
change in the current recommendation. 
Regarding the pessimistic case, RRPs are not considered to be taxed under 
differentiated regulatory regimes within all regions. Therefore, excise taxes on 
these products are expected to be in line with the ones for regular cigarettes, and 
subsequently increase by 0,82% a year going forward. Gross margin is not 
expected to revert to past figures, given PMI’s inability to increase the efficiency 
of its RRP production, failing to achieve a gross margin aligned with the one of its 
premium brands. Therefore, from 2021 onwards, gross margin is expected to 
stabilize at 62,9%. 
This last scenario yields an expected target share price of $68,10, resulting in 
an estimated one-year return of 9,0% (including expected capital gains and cash 
dividends), given the current share price, consequently changing the investment 
recommendation to HOLD. 
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Income Statement
$ in millions 2014 2015 2016 2017 2018 2019E 2020E 2021E 2022E 2023E 2024E 2025F 2026E 2027E 2028E
Core Business
Net Revenues
Combustible Products
European Union 29 058     26 533     27 067     27 261     28 354     28 562     29 015     29 084     28 589     27 265     24 671     20 003     19 406     18 768      18 088      
Eastern Europe, Middle East & Africa 21 928     18 328     18 276     17 886     18 107     18 294     18 824     18 985     18 761     18 194     17 046     14 964     14 751     14 522      14 278      
Asia 19 255     19 434     19 865     19 325     19 392     19 719     20 343     20 983     21 470     21 969     22 453     22 918     23 562     24 214      24 873      
Latin America & Canada 9 865      9 547      9 006      9 833      9 383      9 200      9 525      9 812      10 022     10 170     10 216     10 071     10 264     10 455      10 644      
Total Revenue Combustible Products 80 106     73 842     74 214     74 305     75 236     75 775     77 707     78 865     78 842     77 598     74 386     67 957     67 982     67 958      67 883      
Reduced-Risk Products
European Union -             30           62           320         527         832         1 336      2 143      3 437      5 515      8 874      14 321     15 709     17 151      18 649      
Eastern Europe, Middle East & Africa -             -             9             158         231         369         607         988         1 590      2 553      4 101      6 584      7 203      7 838        8 491        
Asia -             35           666         3 310      4 119      4 361      4 690      5 044      5 368      5 717      6 095      6 506      6 753      7 006        7 264        
Latin America & Canada -             1             2             5             13           24           46           85           156         284         519         946         1 037      1 133        1 233        
Total Revenue Reduced-Risk Products -             66           739         3 793      4 890      5 586      6 679      8 261      10 551     14 070     19 588     28 357     30 702     33 128      35 636      
Total PMI Net Revenues 80 106     73 908     74 953     78 098     80 126     81 361     84 386     87 126     89 393     91 667     93 975     96 314     98 684     101 086    103 519    
Excise taxes
European Union 20 219 -    18 495 -    18 967 -    19 262 -    20 170 -    20 528 -    21 197 -    21 808 -    22 367 -    22 893 -    23 428 -    23 971 -    24 524 -    25 085 -     25 656 -     
Eastern Europe, Middle East & Africa 13 006 -    10 964 -    11 286 -    11 346 -    11 531 -    11 735 -    12 218 -    12 559 -    12 796 -    13 046 -    13 297 -    13 550 -    13 804 -    14 060 -     14 317 -     
Asia 10 527 -    11 266 -    11 850 -    11 845 -    12 304 -    12 601 -    13 100 -    13 620 -    14 045 -    14 488 -    14 939 -    15 398 -    15 864 -    16 337 -     16 818 -     
Latin America & Canada 6 587 -     6 389 -     6 165 -     6 897 -     6 587 -     6 467 -     6 709 -     6 939 -     7 135 -     7 329 -     7 525 -     7 723 -     7 923 -     8 124 -       8 326 -       
Total Excise Taxes 50 339 -    47 114 -    48 268 -    49 350 -    50 592 -    51 331 -    53 224 -    54 927 -    56 343 -    57 756 -    59 189 -    60 642 -    62 114 -    63 606 -     65 116 -     
Total PMI Net Revenues (excl. Excise Taxes) 29 767     26 794     26 685     28 748     29 535     30 030     31 162     32 199     33 050     33 912     34 785     35 672     36 570     37 480      38 402      
Cost of Sales 10 436 -    9 365 -     9 391 -     10 432 -    10 777 -    11 017 -    11 495 -    11 942 -    12 219 -    12 499 -    12 781 -    13 066 -    13 353 -    13 643 -     13 935 -     
Gross Profit 19 331     17 429     17 294     18 316     18 758     19 012     19 667     20 257     20 831     21 413     22 004     22 606     23 217     23 837      24 467      
Marketing and administration costs 4 997 -     4 827 -     4 618 -     4 342 -     4 431 -     4 506 -     4 675 -     4 831 -     4 959 -     5 088 -     5 219 -     5 352 -     5 487 -     5 623 -       5 762 -       
Advertising expenses 439 -        448 -        405 -        830 -        967 -        1 114 -     1 311 -     1 355 -     1 391 -     1 427 -     1 464 -     1 501 -     1 539 -     1 577 -       1 616 -       
Rent expenses 336 -        286 -        284 -        313 -        351 -        357 -        370 -        383 -        393 -        403 -        414 -        424 -        435 -        446 -         457 -          
R&D expense 433 -        423 -        429 -        453 -        457 -        457 -        467 -        475 -        481 -        487 -        493 -        500 -        507 -        514 -         521 -          
ow with RRP -             296 -        309 -        335 -        344 -        350 -        363 -        375 -        385 -        395 -        406 -        416 -        426 -        437 -         448 -          
ow with combustible products -             127 -        120 -        118 -        113 -        107 -        104 -        100 -        96 -          92 -          88 -          84 -          80 -          77 -           73 -           
EBITDA 13 126     11 445     11 558     12 378     12 552     12 578     12 843     13 213     13 607     14 008     14 415     14 829     15 250     15 677      16 112      
Amortization of intangibles 93 -          82 -          74 -          88 -          89 -          91 -          94 -          97 -          100 -        102 -        105 -        108 -        110 -        113 -         116 -          
Depreciation 796 -        672 -        669 -        787 -        907 -        981 -        1 084 -     1 192 -     1 302 -     1 422 -     1 458 -     1 496 -     1 533 -     1 571 -       1 610 -       
Total Operating Income (EBIT) 12 237     10 691     10 815     11 503     11 556     11 506     11 665     11 924     12 206     12 484     12 851     13 226     13 606     13 993      14 386      
Recurrent Operational Taxes 3 090 -     2 559 -     2 535 -     2 734 -     2 658 -     2 646 -     2 683 -     2 743 -     2 807 -     2 871 -     2 956 -     3 042 -     3 129 -     3 218 -       3 309 -       
Non-recurrent Operational Taxes 562 -        505 -        545 -        1 893 -     -             -             -             -             -             -             -             -             -             -               -               
NOPLAT 8 585      7 626      7 735      6 876      8 898      8 860      8 982      9 182      9 398      9 612      9 896      10 184     10 477     10 775      11 077      
Non-Core Business
Asset Impairment and exit costs 535 -        68 -          -             -             -             -             -             -             -             -             -             -             -             -               -               
Interest Expense, net (derivatives not designated as Hedging 
Instruments - Note 15) -             1 -            24 -          60 -          60 -          60 -          60 -          60 -          60 -          60 -          60 -          60 -          60 -          60 -           60 -           
Non-Core before taxes 535 -        69 -          24 -          60 -          60 -          60 -          60 -          60 -          60 -          60 -          60 -          60 -          60 -          60 -           60 -           
Non-core taxes 187         24           8             21           13           13           13           13           13           13           13           13           13           13            13            
Non-core after taxes 348 -        45 -          16 -          39 -          47 -          47 -          47 -          47 -          47 -          47 -          47 -          47 -          47 -          47 -           47 -           
Equity income/loss in unconsolidated subsidiaries, net 105         105         94           59           91           91           91           91           91           91           91           91           91           91            91            
Other comprehensive income:
Change in currency translation adjustments 1 751 -     2 249 -     9 -            328         328         328         328         328         328         328         328         328         328         328          328           
Change in net loss and prior service cost 975 -        309 -        236 -        751         751         751         751         751         751         751         751         751         751         751          751           
Change in fair value of derivatives accounted for as hedges 60           64 -          38           55 -          55 -          55 -          55 -          55 -          55 -          55 -          55 -          55 -          55 -          55 -           55 -           
Non-Core Result 2 909 -     2 562 -     129 -        1 044      1 067      1 067      1 067      1 067      1 067      1 067      1 067      1 067      1 067      1 067        1 067        
Financial
Interest expense, net 1 052 -     1 007 -     867 -        854 -        600 -        570 -        671 -        779 -        774 -        773 -        744 -        713 -        681 -        648 -         613 -          
Interest Tax Shield 368         352         303         299         126         120         141         164         163         162         156         150         143         136          129           
Financial Result 684 -        655 -        564 -        555 -        474 -        451 -        530 -        615 -        611 -        611 -        588 -        564 -        538 -        512 -         484 -          
Total Comprehensive Income 4 992      4 410      7 043      7 365      9 492      9 477      9 519      9 634      9 854      10 069     10 375     10 687     11 006     11 330      11 661      
Appendix 
Financial Statements 
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Balance Sheet
$ in millions 2014 2015 2016 2017 2018 2019E 2020E 2021E 2022E 2023E 2024E 2025F 2026E 2027E 2028E
Core Business
Operating Assets
Operating cash 595         536         534         575         591         601         623         644         661         678         696         713         731         750         768         
Receivables 3 497      2 614      3 210      3 445      3 652      3 831      4 102      4 373      4 632      4 903      5 190      5 491      5 808      6 142      6 493      
Inventories 8 592      8 473      9 017      8 806      9 667      9 979      10 511     11 022     11 479     11 948     12 255     12 568     12 884     13 205     13 530     
Other current assets 391         340         485         497         511         519         539         557         571         586         601         617         632         648         664         
Property, plant, and equipment, at cost (net) 6 071      5 721      6 064      7 271      7 765      8 403      9 280      10 206     11 149     12 175     12 489     12 807     13 129     13 456     13 787     
Goodwill 8 388      7 415      7 324      7 666      8 120      8 256      8 567      8 852      9 086      9 323      9 563      9 807      10 054     10 304     10 557     
Other intangible assets (net) 2 985      2 623      2 470      2 432      2 771      2 818      2 924      3 021      3 101      3 182      3 264      3 347      3 431      3 517      3 603      
Deferred income taxes 533         488         859         1 007      763         776         805         832         854         876         899         922         945         968         992         
Other assets 1 010      1 190      1 037      1 843      1 893      1 925      1 998      2 064      2 119      2 174      2 230      2 287      2 344      2 403      2 462      
Total Operating Assets 32 062     29 400     31 000     33 542     35 733     37 107     39 349     41 571     43 651     45 845     47 186     48 558     49 960     51 393     52 857     
Operating Liabilities
Accounts payable 1 242      1 289      1 666      2 242      2 299      2 333      2 416      2 492      2 531      2 570      2 608      2 647      2 685      2 723      2 761      
Accrued liabilities 8 358      8 015      8 972      7 964      8 810      8 958      9 295      9 605      9 859      10 115     10 376     10 640     10 908     11 180     11 455     
Income taxes 1 078      970         832         812         973         990         1 027      1 061      1 089      1 118      1 147      1 176      1 205      1 235      1 266      
Deferred income taxes 1 707      1 749      1 897      799         821         835         866         895         919         943         967         991         1 016      1 042      1 067      
Employment costs 633         658         643         582         666         677         702         726         745         764         784         804         824         845         866         
Income taxes and other liabilities 480         470         700         1 938      940         956         992         1 025      1 052      1 079      1 107      1 135      1 164      1 193      1 222      
Total Operating Liabilities 13 498     13 151     14 710     14 337     14 509     14 748     15 299     15 803     16 194     16 589     16 989     17 394     17 804     18 218     18 637     
Invested Capital Core Business 18 564     16 249     16 290     19 205     21 224     22 360     24 050     25 768     27 457     29 256     30 197     31 164     32 156     33 174     34 220     
Non-Core Business
Non-Core Assets
Investments in unconsolidated subsidiaries 1 083      890         1 011      1 074      1 074      1 074      1 074      1 074      1 074      1 074      1 074      1 074      1 074      1 074      1 074      
Receivables from unconsolidated subsidiaries 407         64           289         293         293         293         293         293         293         293         293         293         293         293         293         
Foreign exchange contracts designated as hedging inst. 370         482         643         118         118         118         118         118         118         118         118         118         118         118         118         
Foreign exchange contracts not designated as hedging inst. 36           92           170         22           22           22           22           22           22           22           22           22           22           22           22           
Excess pension assets 42           47           33           47           47           47           47           47           47           47           47           47           47           47           47           
Total Non-Core Assets 1 938      1 575      2 146      1 554      1 554      1 554      1 554      1 554      1 554      1 554      1 554      1 554      1 554      1 554      1 554      
Non-Core Liabilities
Foreign exchange contracts designated as hedging inst. 25           143         102         1 077      1 077      1 077      1 077      1 077      1 077      1 077      1 077      1 077      1 077      1 077      1 077      
Foreign exchange contracts not designated as hedging inst. 126         29           61           51           51           51           51           51           51           51           51           51           51           51           51           
Other liabilities from unconsolidated subsidiaries (cont.) 93           100         -             -             -             -             -             -             -             -             -             -             -             -             -             
Total Non-Core Liabilities 244         272         163         1 128      1 128      1 128      1 128      1 128      1 128      1 128      1 128      1 128      1 128      1 128      1 128      
Invested Capital Non-Core Business 1 694      1 303      1 983      426         426         426         426         426         426         426         426         426         426         426         426         
Financial
Financial Assets
Excess of cash and cash equivalents 1 087      2 881      3 705      7 872      -             -             -             -             -             -             -             -             -             -             -             
Notes receivables  from unconsolidated subsidiaries 100         100         -             -             -             -             -             -             -             -             -             -             -             -             -             
Total Financial Assets 1 187      2 981      3 705      7 872      -             -             -             -             -             -             -             -             -             -             -             
Financial Liabilities
Short term borrowings 1 208      825         643         499         247         237         234         233         231         231         222         213         203         193         183         
Current position of long-term debt 1 318      2 405      2 573      2 506      1 554      1 267      1 062      1 056      1 049      1 048      1 009      967         924         878         831         
Long-term debt 26 929     25 250     25 851     31 334     22 311     21 432     21 173     21 046     20 913     20 885     20 104     19 279     18 412     17 504     16 555     
Unfunded pension liabilities 1 396      1 729      1 963      1 477      708         680         671         667         663         662         638         611         584         555         525         
Unfunded postretirement liabilities 238         211         227         248         189         182         179         178         177         177         170         163         156         148         140         
Minority interests 1 426      1 768      1 788      1 856      1 856      1 856      1 856      1 856      1 856      1 856      1 856      1 856      1 856      1 856      1 856      
Total Financial Liabilities 32 515     32 188     33 045     37 920     29 561     28 470     28 148     27 990     27 825     27 790     26 820     25 795     24 719     23 591     22 414     
Net Financial Assets 31 328 -    29 207 -    29 340 -    30 048 -    29 561 -    28 470 -    28 148 -    27 990 -    27 825 -    27 790 -    26 820 -    25 795 -    24 719 -    23 591 -    22 414 -    
PMI Shareholders' Equity (As Reported) 12 629 -    13 244 -    12 688 -    12 086 -    9 580 -     7 353 -     5 341 -     3 465 -     1 611 -     223         2 135      4 125      6 194      8 340      10 563     
Dividends payable 1 559 -     1 589 -     1 621 -     1 669 -     1 669 -     1 669 -     1 669 -     1 669 -     1 669 -     1 669 -     1 669 -     1 669 -     1 669 -     1 669 -     1 669 -     
PMI Shareholders' Equity 11 070 -    11 655 -    11 067 -    10 417 -    7 911 -     5 684 -     3 672 -     1 796 -     58           1 892      3 804      5 794      7 863      10 009     12 232     
2. Balance Sheet 
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3. Cash Flow Maps and DCF 
 
 
 
 
 
 
 
Cash Flow Maps
$ in millions 2015 2016 2017 2018 2019E 2020E 2021E 2022E 2023E 2024E 2025F 2026E 2027E 2028E
Core Business
EBIT 10 691    10 815    11 503    11 556    11 506    11 665    11 924    12 206     12 484     12 851     13 226     13 606     13 993     14 386     
Recurrent taxes 2 559 -     2 535 -     2 734 -     2 658 -     2 646 -     2 683 -     2 743 -     2 807 -     2 871 -     2 956 -     3 042 -     3 129 -     3 218 -     3 309 -     
Non-recurrent taxes 505 -       545 -       1 893 -     -             -             -             -             -             -             -             -             -             -             -             
NOPLAT 7 626      7 735      6 876      8 898      8 860      8 982      9 182      9 398      9 612      9 896      10 184     10 477     10 775     11 077     
D&A 754        743        875        996        1 072      1 178      1 289      1 402      1 524      1 563      1 603      1 644      1 684      1 726      
Operational Cash Flow 8 380      8 478      7 751      9 894      9 932      10 160    10 471    10 800     11 136     11 459     11 787     12 120     12 459     12 803     
Net CAPEX 404 -       1 086 -     2 082 -     1 490 -     1 710 -     2 055 -     2 214 -     2 345 -     2 550 -     1 877 -     1 921 -     1 966 -     2 011 -     2 057 -     
CF from ∆ NWC 708        87 -         529 -       33 -         312 -       387 -       402 -       426 -        448 -        299 -        315 -        331 -        349 -        367 -        
CF from ∆ Other Operating Assets 1 200      26          1 258 -     599 -       227 -       519 -       476 -       390 -        395 -        401 -        406 -        412 -        418 -        423 -        
CF from ∆ Other Operating Liabilities 57          363        79          892 -       41          93          85          70           71           72           73           74           75           76           
Investment Cash Flow 1 561      784 -       3 790 -     3 015 -     2 208 -     2 868 -     3 007 -     3 091 -     3 323 -     2 505 -     2 570 -     2 636 -     2 703 -     2 771 -     
Unlevered Operational FCF 9 942      7 694      3 961      6 879      7 724      7 292      7 464      7 709      7 814      8 954      9 217      9 485      9 756      10 032     
Non-Core Business
Operational Cash Flow 2 562 -     129 -       1 044      1 067      1 067      1 067      1 067      1 067      1 067      1 067      1 067      1 067      1 067      1 067      
Investment Cash Flow 391        680 -       1 557      -             -             -             -             -             -             -             -             -             -             -             
Non-Operational FCF 2 171 -     809 -       2 601      1 067      1 067      1 067      1 067      1 067      1 067      1 067      1 067      1 067      1 067      1 067      
Total Free Cash Flow 7 771      6 886      6 562      7 946      8 791      8 359      8 531      8 777      8 881      10 022     10 285     10 552     10 823     11 099     
Financial
Financial Result 1 007 -     867 -       854 -       600 -       570 -       671 -       779 -       774 -        773 -        744 -        713 -        681 -        648 -        613 -        
Tax Shield 352        303        299        126        120        141        164        163         162         156         150         143         136         129         
Investment in Net Financial Assets 2 121 -     133        708        487 -       1 091 -     322 -       158 -       165 -        35 -          971 -        1 024 -     1 077 -     1 128 -     1 178 -     
∆ Equity in Cash 4 995 -     6 455 -     6 715 -     6 985 -     7 250 -     7 507 -     7 758 -     8 001 -     8 236 -     8 463 -     8 697 -     8 937 -     9 184 -     9 438 -     
Financial Free Cash Flow 7 771 -     6 886 -     6 562 -     7 946 -     8 791 -     8 359 -     8 531 -     8 777 -     8 881 -     10 022 -    10 285 -    10 552 -    10 823 -    11 099 -    
Discounted Cash Flow
$ in millions 2019E 2020E 2021E 2022E 2023E 2024E 2025F 2026E 2027E 2028E
NOPLAT 10 160     10 471     10 800     11 136     11 459     11 787     12 120     12 459     12 803     
Investment Cash Flow 2 868 -     3 007 -     3 091 -     3 323 -     2 505 -     2 570 -     2 636 -     2 703 -     2 771 -     
Invested Capital 22 360               25 228     28 235     31 326     34 648     37 153     39 723     42 358     45 061     47 833     
Unlevered Operational FCF 7 724                 7 292      7 464      7 709      7 814      8 954      9 217      9 485      9 756      10 032     
ROIC 45,4% 41,5% 38,3% 35,6% 33,1% 31,7% 30,5% 29,4% 28,4%
RR 28,2% 28,7% 28,6% 29,8% 21,9% 21,8% 21,7% 21,7% 21,6%
RONIC 10,8% 11,0% 10,9% 9,7% 13,1% 13,0% 12,9% 12,7%
g 3,1% 3,1% 3,1% 2,9% 2,9% 2,8% 2,8% 2,8%
Be 0,78 0,77 0,77 0,77 0,76 0,75 0,75 0,74 0,74
Re 7,46% 7,44% 7,42% 7,40% 7,37% 7,34% 7,31% 7,28% 7,25%
Debt/Equity 0,153 0,146 0,140 0,135 0,126 0,116 0,107 0,098 0,090
Debt/EV 13,25% 12,77% 12,31% 11,92% 11,16% 10,42% 9,68% 8,96% 8,24%
WACC 6,86% 6,86% 6,86% 6,87% 6,87% 6,88% 6,88% 6,89% 6,90%
EV 192557 198469 204622 210958 217632 223635 229802 236138 242653 249354
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Disclosures and Disclaimers 
▪ Report  Recommendations 
Buy Expected total return (including expected capital gains and expected dividend yield) 
of more than 10% over a 12-month period. 
Hold Expected total return (including expected capital gains and expected dividend yield) 
between 0% and 10% over a 12-month period. 
Sell Expected negative total return (including expected capital gains and expected 
dividend yield) over a 12-month period. 
 
 
This report was prepared by António Fertusinhos and Nuno Paulino, Master in Finance students of Nova 
School of Business and Economics (“Nova SBE”), within the context of the Field Lab – Equity Research. 
This report is issued and published exclusively for academic purposes, namely for academic evaluation and 
master graduation purposes, within the context of said Field Lab – Equity Research. It is not to be construed 
as an offer or a solicitation of an offer to buy or sell any security or financial instrument. 
This report was supervised by a Nova SBE faculty member, acting merely in an academic capacity, who 
revised the valuation methodology and the financial model. 
Given the exclusive academic purpose of the reports produced by Nova SBE students, it is Nova SBE 
understanding that Nova SBE, the author, the present report and its publishing, are excluded from the 
persons and activities requiring previous registration from local regulatory authorities. As such, Nova SBE, its 
faculty and the author of this report have not sought or obtained registration with or certification as financial 
analyst by any local regulator, in any jurisdiction. In Portugal, neither the author of this report nor his/her 
academic supervisor is registered with or qualified under COMISSÃO DO MERCADO DE VALORES MOBILIÁRIOS 
(“CMVM”, the Portuguese Securities Market Authority) as a financial analyst. No approval for publication or 
distribution of this report was required and/or obtained from any local authority, given the exclusive academic 
nature of the report. 
The additional disclaimers also apply: 
USA: Pursuant to Section 202 (a) (11) of the Investment Advisers Act of 1940, neither Nova SBE nor the 
author of this report are to be qualified as an investment adviser and, thus, registration with the Securities and 
Exchange Commission (“SEC”, United States of America’s securities market authority) is not necessary. 
Neither the author nor Nova SBE receive any compensation of any kind for the preparation of the reports. 
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Germany: Pursuant to §34c of the WpHG (Wertpapierhandelsgesetz, i.e., the German Securities Trading 
Act), this entity is not required to register with or otherwise notify the Bundesanstalt für 
Finanzdienstleistungsaufsicht (“BaFin”, the German Federal Financial Supervisory Authority). It should be 
noted that Nova SBE is a fully-owned state university and there is no relation between the student’s equity 
reports and any fund raising programme. 
UK: Pursuant to section 22 of the Financial Services and Markets Act 2000 (the “FSMA”), for an activity to be 
a regulated activity, it must be carried on “by way of business”. All regulated activities are subject to prior 
authorization by the Financial Conduct Authority (“FCA”). However, this report serves an exclusively 
academic purpose and, as such, was not prepared by way of business. The author - a Master’s student - is 
the sole and exclusive responsible for the information, estimates and forecasts contained herein, and for 
the opinions expressed, which exclusively reflect his/her own judgment at the date of the report. Nova SBE 
and its faculty have no single and formal position in relation to the most appropriate valuation method, 
estimates or projections used in the report and may not be held liable by the author’s choice of the latter. 
The information contained in this report was compiled by students from public sources believed to be reliable, 
but Nova SBE, its faculty, or the students make no representation that it is accurate or complete, and accept 
no liability whatsoever for any direct or indirect loss resulting from the use of this report or of its content. 
Students are free to choose the target companies of the reports. Therefore, Nova SBE may start covering 
and/or suspend the coverage of any listed company, at any time, without prior notice. The students or Nova 
SBE are not responsible for updating this report, and the opinions and recommendations expressed herein 
may change without further notice. 
The target company or security of this report may be simultaneously covered by more than one student. 
Because each student is free to choose the valuation method, and make his/her own assumptions and 
estimates, the resulting projections, price target and recommendations may differ widely, even when referring 
to the same security. Moreover, changing market conditions and/or changing subjective opinions may lead to 
significantly different valuation results. Other students’ opinions, estimates and recommendations, as well as 
the advisor and other faculty members’ opinions may be inconsistent with the views expressed in this report. 
Any recipient of this report should understand that statements regarding future prospects and performance 
are, by nature, subjective, and may be fallible. 
This report does not necessarily mention and/or analyze all possible risks arising from the investment in the 
target company and/or security, namely the possible exchange rate risk resulting from the security being 
denominated in a currency either than the investor’s currency, among many other risks. 
The purpose of publishing this report is merely academic and it is not intended for distribution among private 
investors. The information and opinions expressed in this report are not intended to be available to any 
person other than Portuguese natural or legal persons or persons domiciled in Portugal. While preparing this 
report, students did not have in consideration the specific investment objectives, financial situation or  
 
  
 
PHILIP MORRIS INTERNATIONAL INC. COMPANY REPORT 
 
 
 
  PAGE 32/42 
 
 
 
particular needs of any specific person. Investors should seek financial advice regarding the appropriateness 
of investing in any security, namely in the security covered by this report. 
The author hereby certifies that the views expressed in this report accurately reflect his/her personal opinion 
about the target company and its securities. He/ She has not received or been promised any direct or indirect 
compensation for expressing the opinions or recommendation included in this report. 
The content of each report has been shown or made public to restricted parties prior to its publication in Nova 
SBE’s website or in Bloomberg Professional, for academic purposes such as its distribution among faculty 
members for students’ academic evaluation. 
Nova SBE is a state-owned university, mainly financed by state subsidies, students tuition fees and 
companies, through donations, or indirectly by hiring educational programs, among other possibilities. Thus, 
Nova SBE may have received compensation from the target company during the last 12 months, related to its 
fundraising programs, or indirectly through the sale of educational, consulting or research services. 
Nevertheless, no compensation eventually received by Nova SBE is in any way related to or dependent on 
the opinions expressed in this report. The Nova School of Business and Economics does not deal for or 
otherwise offer any investment or intermediation services to market counterparties, private or intermediate 
customers. 
This report may not be reproduced, distributed or published, in whole or in part, without the explicit previous 
consent of its author, unless when used by Nova SBE for academic purposes only. At any time, Nova SBE 
may decide to suspend this report reproduction or distribution without further notice. Neither this document 
nor any copy of it may be taken, transmitted or distributed, directly or indirectly, in any country either than 
Portugal or to any resident outside this country. The dissemination of this document other than in Portugal or 
to Portuguese citizens is therefore prohibited and unlawful.
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This individual report aims at a more comprehensive analysis of one of the main risk factors 
to which PMI’s business is exposed to and has been recurrently identified in the company’s 
annual report – excise taxation on tobacco products. 
Historically, cigarettes have been subject to a substantial amount of taxes, not only in the 
form of excise taxes but also sales taxes (VAT) and import duties. The historical upward trend 
is expected to continue as it represents an important income stream for governments and a 
critical measure to mitigate the negative externality of smoking, stimulating tobacco 
consumption reduction. As estimated by the World Health Organization (WHO), raising 
tobacco taxes to increase prices by 10% is estimated to reduce tobacco consumption by 4% in 
high-income countries and by around 5% in low and middle-income countries, on average. 
This study, conducted by the WHO with a worldwide sample of countries, demonstrates how 
impactful and significant taxes rises have been for the downward trend of the industry 
volumes, in the last years. 
The worldwide scope of PMI’s operations exposes the company to different tax structures and 
tax regimes that diverge in the type of applicable tax and on the type of product, depending on 
the jurisdiction. Excise taxes can be either specific – when the tax is a fixed amount charged 
per quantity, usually per cigarette, pack or kilogram - or ad valorem – when the tax is 
charged as a percentage of the retail price. 
As for the type of product, cigarettes are the highest taxed category of products, but there are 
other such as fine cut smoking tobacco (intended for the rolling of cigarettes), cigars and 
cigarillos, pipe tobacco and other smokeless tobacco products, which are usually subject to 
a reduced excise tax rate. 
Excise tax structures vary considerably from country to country, mainly due to the inexistence 
of a best fit system since each one has its advantages and shortcomings, mostly regarding the 
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adjustment for inflation, the manufacturers’ pricing strategy, the effectiveness of reducing 
tobacco consumption and the tax administration capacity. Consequently, tobacco products 
can be taxed uniformly, using a specific or ad valorem excise system only, opposed to using 
a mixed excise system, with both components. Moreover, some countries apply a minimum 
specific floor tax under which the tax liability of both excises cannot fall, to ensure there is 
not an incentive for manufacturers to produce low priced products in order to reduce their tax 
liability, increasing the consumption of lower quality cigarettes. 
Regardless of the excise tax structure, tax authorities can decide on using a differential 
(tiered) system, applying differential tax rates based on a specific characteristic of the 
cigarettes (e.g., price, length, filter). 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit 56: Breakdown of taxes on the most sold brand of cigarettes in PMI’s most relevant operating 
countries 
Source: World Health Organization report on the global tobacco epidemic (2017) 
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In Exhibit 56, there is evidence of a high degree of asymmetry in the tax structures and 
applicable tax rates not only between different regions, but also within PMI’s most relevant 
operating countries in each region. Consequently, profit margins and cigarettes demand are 
severely affected by the excise taxes increases and require different actions regarding the 
products’ pricing and strategy, enabling the company to reduce the negative effect on margins 
without deteriorating further demand. 
According to an Amundi Report on the tobacco industry50, specific component on the excise 
tax structure create a tax leverage that benefits manufacturers due to the fixed nature of the 
specific excise tax. Consequently, any increase on the retail selling price, remaining 
everything else equal, automatically increases the take of the manufacturer, as opposed to a 
uniform ad valorem tax structure where the percentage take for the manufacturer remains 
constant. The magnitude of the manufacturer’s percentage take increase will depend on the 
proportion of specific excise tax component, being more impactful as the overall excise tax is 
composed of a higher specific component. 
One of the governments’ objectives of charging excise taxes on tobacco products is to 
encourage a reduction in consumption and incentivize the shift towards higher quality 
products, which are less harmful for consumers health, when the first objective is not fully 
met. Specific excise taxes place a proportionately higher tax burden on low-price brands 
(which theoretically have lower quality) when comparing to higher-price ones, since the tax is 
uniformly applied to all. In this context, the price gap between brands is reduced as well as 
the incentive of shifting consumption from premium to cheaper brands.51 Therefore, PMI’s 
strategy focused on premium brands places the company in a better position to capture value 
by operating in countries with higher specific excise tax component. 
                                                 
50 Tobacco: “I’ve got the (pricing) power” (2016), Amundi Asset Management – Research, Strategy and Analysis 
51 Economics of tobacco taxation toolkit (2018), World Bank Group 
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Cigarettes are the category that contributes the most for PMI’s revenues and the one with the 
highest overall excise tax rate within all tobacco products’ categories. According to the 
company report, depending on national legislation, HTU are generally taxed under a 
dedicated excise category or as OTP (Other Tobacco Products) that establishes an excise 
tax differentiation to cigarettes, at reduced levels. 
Conducting a disruptive strategy in the tobacco industry, aiming at a shift from cigarettes to 
reduced-risk products, PMI expects to convince regulators of RRPs’ benefits and to reduce its 
tax liability as this segment becomes more representative in the tobacco market. Given the 
novelty and evolutionary nature of these products in the market, many legislators have 
decided to categorize heated tobacco products as OTP, for the time being, which is currently 
benefiting PMI due to the lower applicable excise tax rate. However, there is still a certain 
risk that this situation might revert, as legislators are still assessing if heated tobacco products 
are indeed less harmful for consumers than conventional cigarettes. 
In order to assess the impact of Philip Morris’ expectations regarding excise taxation of 
reduced-risk products, a hypothetical scenario was created in which the excise tax rate for 
RRPs was assumed to be the one applicable to OTP, for each business region of PMI’s 
operations. Therefore, for each region, the applicable excise tax rate for RRPs was determined 
by the average of the OTP rates of the relevant countries above-mentioned in Exhibit 56. As 
for the combustible products’ excise tax rate for 2019, it was considered the overall excise tax 
rate as % of revenues of 2016 instead of 2017, such that it does not to reflect the impact of a 
reduced excise rate, already felt in the company’s financials in the latter year. 
Consequently, the reduced excise rate for RRPs is applied from 2019 onwards and both 
combustible and RRPs rates are considered to grow 0,62% every year (the average growth of 
excise taxes in all regions) to replicate the historical upward trend of excise taxes.  
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The excise tax rates (as % of revenues) for the explicit forecasted period are computed as a 
weighted-average of the combustible and RRPs’ revenue (Exhibit 57). 
 
 
 
 
 
 
 
 
 
 
 
The estimated impact in PMI’s share price of the hypothetical scenario translates into an 
upward movement of the share price to $152,83. This impact implicitly assumes that prices 
of HTU will remain at the same level, which consequently suggests that Philip Morris 
captures all the value of the excise tax reduction. 
This scenario illustrates the important role that excise taxes play in the tobacco industry and 
how impactful they can be for the value of tobacco companies. Further analysis could be 
conducted in the attempt to establish a more accurate proxy for the estimated excise tax rate 
for RRPs in each region. 
                             
Exhibit 57: Forecasted excise tax rates as % of revenues under PMI’s expectations 
Source: Analyst estimates and World Health Organization 
Note: Latin America & Canada are not expected to have a reduce excise rate for RRPs since Canada does not have a tax differentiation for 
OTP and RRPs are government banned from Mexico and Argentina. 
2018 2019E 2020E 2021E 2022E 2023E 2024E 2025F 2026E 2027E 2028E
European Union
Combustibles Products Tax 69,91% 70,35% 70,79% 71,23% 71,67% 72,11% 72,56% 73,01% 73,47% 73,92% 74,38%
% growth 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62%
Reduced-Risk Products Tax 69,91% 23,45% 23,60% 23,74% 23,89% 24,04% 24,19% 24,34% 24,49% 24,64% 24,79%
% growth 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62%
Excise taxes as % of revenue 69,91% 69,02% 68,71% 67,97% 66,54% 64,03% 59,77% 52,71% 51,56% 50,39% 49,21%
EEMA
Combustibles Products Tax 61,72% 62,11% 62,49% 62,88% 63,27% 63,67% 64,06% 64,46% 64,86% 65,26% 65,67%
% growth 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62%
Reduced-Risk Products Tax 61,72% 25,62% 25,78% 25,94% 26,10% 26,26% 26,43% 26,59% 26,75% 26,92% 27,09%
% growth 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62%
Excise taxes as % of revenue 61,72% 61,39% 61,34% 61,05% 60,37% 59,06% 56,76% 52,89% 52,36% 51,82% 51,28%
Asia
Combustibles Products Tax 57,72% 58,08% 58,44% 58,80% 59,17% 59,53% 59,90% 60,28% 60,65% 61,03% 61,41%
% growth 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62%
Reduced-Risk Products Tax 57,72% 25,44% 25,60% 25,75% 25,91% 26,08% 26,24% 26,40% 26,57% 26,73% 26,90%
% growth 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62%
Excise taxes as % of revenue 57,72% 52,17% 52,28% 52,40% 52,52% 52,63% 52,72% 52,79% 53,06% 53,33% 53,61%
Latin America & Canada
Combustibles Products Tax 68,44% 68,86% 69,29% 69,72% 70,16% 70,59% 71,03% 71,47% 71,92% 72,37% 72,82%
% growth 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62%
Reduced-Risk Products Tax 68,44% 68,86% 69,29% 69,72% 70,16% 70,59% 71,03% 71,47% 71,92% 72,37% 72,82%
% growth 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62% 0,62%
Excise taxes as % of revenue 68,44% 68,86% 69,29% 69,72% 70,16% 70,59% 71,03% 71,47% 71,92% 72,37% 72,82%
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IQOS U.S. Launch Assessment   
Following its vision of a smoke-free future, Philip Morris International (PMI) is now awaiting 
regulatory approval to commercialize its reduced-risk product IQOS within the United States 
market, under its old parent company Altria. This key milestone would represent a disruptive 
entry in the second largest tobacco market worldwide, enforcing the IQOS momentum as 
PMI’s main growth driver in an attempt to revert current industry declining volumes. In this 
report, the U.S. tobacco market will be assessed together with the investment opportunity it 
presents for Philip Morris as well as the related risks.       
Current PMI Situation  
Philip Morris stock fell nearly 40% in 2018 due to investors’ sentiment regarding declining 
smoking rates, strong competition from its peers, currency headwinds in Argentina and 
Turkey and higher interest rates, resulting in less attractive dividends. However, during the 
first three quarters of 2018, PMI’s market share increased 30 basis points to 38,4%, 
strengthening the market positioning of its cigarette and reduced-risk products’ portfolio. 
Although PMI’s traditional cigarette shipment volume fell 2,7% to 550,1 billion units during 
the mentioned period, the decline was fully offset by the 42% growth of its reduced-risk 
segment (namely through IQOS) to 29,2 billion units. 52 PMI therefore relies on the robust 
demand for IQOS to drive its future growth, hence sees the U.S. market, in which the 
company is not yet commercializing IQOS, as an investment opportunity. 
U.S. Tobacco Market 
The U.S tobacco market is under the regulatory jurisdiction of the U.S Food & Drug 
Administration (FDA). It is the second largest in terms of revenues with over $98 billion in 
2018, only standing behind China with over $200 billion. For the last 8 years, the market 
                                                 
52 The Motley Fool 
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retracted around 1,3%, however, lately displaying a slight positive trend in revenues with a 
compounded annual growth rate (CAGR) of 0,24% between 2014 and 2018 (Exhibit 58).   
 
 
 
 
 
This market is mainly guided by two economic drivers – shipment volumes (defined by the 
smoking rates and existing population) and tobacco prices.   
Regarding smoking rates, these have been decreasing since 2015 while the U.S adult 
population increasing at nearly 0,7% a year53, resulting in declining industry shipment 
volumes (Exhibit 59). During the last 4 years, shipment volumes (including all smoking 
products) declined over 6,1%, while in the same period, revenues saw no significant change 
reflecting the pricing power producers have on consumers who are relatively price inelastic. 
 
 
 
 
 
While the overall tobacco market has registered slow growths due to decreasing volumes of 
traditional tobacco products, e-cigarette revenues have registered a CAGR of nearly 24,5% 
                                                 
53 United Nations Department of Economic and Social Affairs 
Exhibit 58: U.S. tobacco market revenues in $ billion (2010 – 2018) 
Source: Statista, April 2018 
Exhibit 59: U.S. tobacco shipment volumes in billion units (2010 – 2018) 
Source: Statista, April 2018 
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between 2014 and 2018 (Exhibit 60), as smokers’ health awareness arises combined with a 
generalized preference for digital products, resulting in a substitution effect by departing from 
the traditional cigarettes. This segment, in which Philip Morris’ reduced-risk product IQOS 
would directly compete, already accounts for 3,7% of the U.S. overall market and is 75% 
controlled by JUUL, a Silicon Valley based start-up founded in 2017.   
There has been significant consolidation within the industry given the 71 completed mergers 
and acquisitions in the past 5 years, amounting to a total of $99,4 billion.54 With the most 
emphasis are the $54,0 billion acquisition of Reynolds American in 2016, the second largest 
player in the U.S behind Altria, by British American Tobacco and the $12,8 billion minority 
acquisition of JUUL by Altria in December 2018, owning now 35% of its stock.55  
Given the current consolidated state of the industry, one could assume British American 
Tobacco and Altria (which jointly dominate the U.S market) would not be vulnerable to new 
players with no brand recognition nor an established business model benefiting from 
economies of scale like theirs, but that is not the case. These companies dominate the 
declining traditional cigarette business and have their positioning threatened by new 
disruptive players, exploring the fast-growing e-cigarette segment (Exhibit 60).  
 
 
 
 
 
 
                                                 
54 Bloomberg 
55 CNBC 
Exhibit 60: U.S. e-cigarette revenues in $ billion (2014 – 2018) 
Source: Statista, April 2018 
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Investment Opportunity 
Philip Morris is waiting for regulatory approval of two applications by the FDA, firstly to 
commercialize IQOS via a “Premarket Tobacco Product Application” (PMTA) within the U.S 
and secondly, to advertise reduced-risk product as a healthier alternative to traditional 
cigarettes through the “Modified Risk Tobacco Product” (MRTP) application.56  
Up to this date, no electronic cigarette manufacturer is allowed to make a reduced-risk claim 
regarding its products and consequently advertise them as such. If the outcome of the FDA 
assessment were to be positive, IQOS would have a significant competitive advantage in an 
industry with marketing for traditional tobacco products heavily regulated, in which radio 
advertisements are not allowed to include music nor any sound effects, while video 
advertisement is limited to static black text on a white background.57 As taxes and marketing 
restrictions on cigarettes are directly related to its high risk profile, PMI expects its reduced-
risk products to be classified accordingly and therefore achieve more favorable regulatory 
regimes. 
Philip Morris expects to commercialize IQOS within the U.S market as soon as 2020, 
according to its CEO, when and if approved by the FDA which he considers the regulatory 
agency with the world’s most comprehensive process and legislation on how to evaluate, 
authorize and survey the post market risks of these products.58 PMI will then commercialize 
IQOS through its partner Altria which already has the right to sell its premium brand 
Marlboro. Since the spin-off in 2008, Altria only sells tobacco products in the U.S, whereas 
PMI does not operate directly in this region. 
 
                                                 
56 University of California San Francisco: Center for Tobacco Control Research and Education 
57 Herington, Matthew R. "Tobacco Regulation In The United States: New Opportunities And Challenges," 
Health Lawyer 23.1 (2010) 
58 Bloomberg Markets and Finance 
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Investment Risks 
As stated before, Altria purchased in late December a 35% stake of possibly IQOS’ main 
future competitor in the U.S. – JUUL, at a time that Altria’s share price had been declining. 
Following the investment, Altria announced that would discontinue its own line of e-
cigarettes to promote its new partner until the FDA approves the commercialization of IQOS. 
As of December 2018, the FDA is still processing both PMI’s applications after a scientific 
panel convened by the same U.S. regulatory agency, in early 2018, recommended against a 
premature approval, given new studies offering evidence of health risks associated with 
IQOS.59 These delays in the approval process might have also played a crucial role in this 
move by Altria. 
Result of Altria’s minority acquisition, JUUL will remain fully independent benefiting not 
only from a $12,8 billion investment but will also have access to its acquirer’s infrastructure 
and services, strengthening its brand and adding momentum to its overwhelming market 
positioning. Thus, by the time IQOS reaches the U.S. (if approved and whether with a 
reduced-risk label granted by the FDA or not), it will face a more competitive environment. 
Furthermore, Altria, which will have a shared interest in what could be the two most 
prominent smoking devices, could have divided loyalties, resulting in a strained partnership as 
any revenues Altria collects through JUUL’s reduced-risk products, will likely come at the 
expense of IQOS, even while trying to break into the market.   
In conclusion, PMI’s 2020 launch prospect may be too optimistic and given JUUL’s current 
strengthened positioning, the longer Philip Morris takes to get IQOS approved by the FDA 
and subsequently launched in the U.S. market, the fewer the chances it will have to succeed as 
in other markets where strongly relied on a first-mover advantage. 
                                                 
59 Reuters  
